Diagnostic value of measuring the amount of 6-hydroxymelatonin sulfate in urine in postmenopausal women with functional abdominal pain;Diagnostyczna wartość oznaczania wydalania siarczanu 6-hydroksymelatoniny z moczem u kobiet z czynnościowymi bólami brzucha w okresie pomenopauzalnym

Przeglad Menopauzalny

Volumn 13, Issue 5, 2009, Pages 251-256

  Wiśniewska Jarosińska, Maria ^a   Chojnacki, Jan ^a   Pawłowicz, Monika ^a   Klupińska, Grazyna ^a   Chojnacki, Cezary ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

6 hydroxymelatonin sulfate; Functional abdominal pain; Melatonin; Menopause

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

ABDOMINAL PAIN; ADULT; ARTICLE; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENTEROCHROMAFFIN CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PINEAL BODY; POSTMENOPAUSE; QUALITY OF LIFE; URINARY EXCRETION;

EID: 73249153617     PISSN: 16438876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Reiter RJ. The pineal and its hormones in the control of reproduction in mammals. Endocr Rev 1980; 1: 109-31.
2. Juszczak M, Michalska M. Wpływ melatoniny na syntezȩ i wydzielanie prolaktyny, hormonu lutenizuja̧cego (LH) i folikulotropowego (FSH). Postȩpy Hig Med Dośw 2006; 60: 431-8.
3. Boczek-Leszczyk E, Juszczak M. Wpływ melatoniny na czynność gonad u człowieka. Pol Merk Lek 2007; 134: 128-30.
4. Karasek M, Reiter RJ. Melatonin and aging. Neuro Endocrinol Lett 2002; 23 (suppl. 1): 14-6.
5. Karasek M, Lewiński A, Reiter RJ. Melatonina: znaczenie kliniczne i zastosowanie terapeutyczne. Endocrynol Pol 2001; 52: 81-100.
6. Mal'tseva LI, Gafarova EA, Garipova GKh. The role of melatonin in regulation of gonadal function and its use in the treatment of pathological climax symptoms. Adv Gerontol 2007; 20: 68-74.
7. Konturek SJ, Konturek PC, Brzozowska I. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol 2007; 58: 381-405.
8. Karasek M, Winczyk K. Melatonin in humans. J Physiol Pharmacol 2006; 57: 19-39.
9. Brzozowski T, Konturek PC, Konturek SJ, et al. The role of melatonin and L-tryptophan in prevention of acute gastric lesions induced by stress, ethanol, ischemia, and aspirin. J Pineal Res 1997; 23: 79-89.
10. Sjöblom M, Flemström G. Melatonin in the duodenal lumen is a potent stimulant of mucosal bicarbonate secretion. J Pineal Res 2003; 34: 288-93.
11. Jaworek J, Nawrot K, Konturek SJ, et al. Melatonin and its precursor, L-tryptophan: influence on pancreatic amylase secretion in vivo and in vitro. J Pineal Res 2004; 36: 155-64.
12. Harlow HJ, Weekley BL. Effect of melatonin on the force of spontaneous contractions of in vitro rat small and large intestine. J Pineal Res 1986; 3: 277-84.
13. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia M, et al. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 2004; 26: 89-93.
14. Bubenik GA. Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept 2001; 10: 350-66.
15. Bubenik GA, Brown GM. Pinealectomy reduces melatonin levels in the serum but not in the gastrointestinal tract of rats. Biol Signals 1997; 6: 40-4.
16. Reiter RJ, Tan DX, Terron MP, et al. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 2007; 54: 1-9.
17. Baskett JJ, Cockrem JF, Antunovich TA. Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function. J Pineal Res 1998; 24: 58-61.
18. Arendt J, Bojkowski C, Franey C, et al. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab 1985; 60: 1166-73.
19. Okatani Y, Morioka N, Wakatsuki A. Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations. J Pineal Res 2000; 28: 111-8.
20. Vakkuri O, Kivelä A, Leppäluoto J, et al. Decrease in melatonin precedes follicle-stimulating hormone increase during perimenopause. Eur J Endocrinol 1996; 135: 188-92.
21. Rönnberg L, Kauppila A, Leppäluoto J, et al. Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. J Clin Endocrinol Metab 1990; 71: 492-6.
22. Itoh MT, Ishizuka B, Kuribayashi Y, et al. Melatonin, its precursors, and synthesizing enzyme activities in the human ovary. Mol Hum Reprod 1999; 5: 402-8.
23. Bódis J, Koppán M, Kornya L, et al. Influence of melatonin on basal and gonadotropin-stimulated progesterone and estradiol secretion of cultured human granulosa cells and in the superfused granulosa cell system. Gynecol Obstet Invest 2001; 52: 198-202.
24. Yie SM, Brown GM, Liu GY, et al. Melatonin and steroids in human pre-ovulatory follicular fluid: seasonal variations and granulosa cell steroid production. Hum Reprod 1995; 10: 50-5.
25. Luboshitzky R, Herer P, Shen-Orr Z. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment. Exp Clin Endocrinol Diabetes 2004; 112: 102-7.
26. Klupińska G, Poplawski T, Drzewoski J, et al. Therapeutic effect of melatonin in patients with functional dyspepsia. J Clin Gastroenterol 2007; 41: 270-4.
27. Song GH, Leng PH, Gwee KA, et al. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 2005; 54: 1402-7.
28. Lu WZ, Gwee KA, Moochhalla S, Ho KY. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2005; 22: 927-34.
29. Saha L, Malhotra S, Rana S, et al. A preliminary study of melatonin in irritable bowel syndrome. J Clin Gastroenterol 2007; 41: 29-32.
30. Luboshitzky R, Levi M, Shen-Orr Z, et al. Long-term melatonin administration does not alter pituitary-gonadal hormone secretion in normal men. Hum Reprod 2000; 15: 60-5.
31. Rajaratnam SM, Dijk DJ, Middleton B, et al. Melatonin phase-shifts human circadian rhythms with no evidence of changes in the duration of endogenous melatonin secretion or the 24-hour production of reproductive hormones. J Clin Endocrinol Metab 2003; 88: 4303-9.
32. Seabra ML, Bignotto M, Pinto LR Jr, Tufik S. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 2000; 29: 193-200.